{"pub": "axios", "url": "https://soa.org/resources/research-reports/2019/econ-impact-non-medical-opioid-use", "downloaded_at": "2019-10-16 13:55:45.465802+00:00", "title": "Economic Impact of Non-Medical Opioid Use in the United States", "language": "en", "text": "October 2019\n\nThe Society of Actuaries\u2019 Mortality and Longevity Strategic Research Committee announce the release of a new report on the economic impact of non-medical opioid use in the United States. Performed by a Milliman team led by Stoddard Davenport with Alexandra Weaver and Matt Caverly, this study estimates the total economic burden of the opioid crisis in the United States from 2015 through 2018 and projects future costs of the opioid epidemic for 2019.\n\nReport\n\nEconomic Impact of Non-Medical Opioid Use in the United States\n\nThank You\n\nThe Sponsor would like to thank the individuals who served on the Project Oversight Group\n\nElizabeth Arias\n\nJean-Marc Fix\n\nSam Gutterman\n\nGina Guzman\n\nAl Klein, Chairperson of the Project Oversight Group\n\nTom Kukla\n\nDonna Megregian\n\nJim Toole\n\nAmy Whinnett\n\nJan Schuh, SOA Sr. Research Administrator\n\nRonora Stryker, SOA Sr. Practice Research Actuary\n\nQuestions Or Comments?\n\nIf you have comments or questions, please send an email to research@soa.org", "description": "This report summarizes a study that estimates the total economic burden of the opioid crisis in the United States from 2015 through 2018 and projects future costs of the opioid epidemic for 2019.", "authors": [], "top_image": "https://soa.org/Static/images/favicons/apple-touch-icon.png", "published_at": "2019-10-16"}